Literature DB >> 19223265

Andersen-Tawil syndrome.

Robin A P Weir, Colin J Petrie, Victoria Murday, Iain N Findlay.   

Abstract

Advances in the understanding of genetic aspects of cardiovascular diseases, together with an increase in the availability of genetic analysis, have resulted in not only increased diagnosis of known inherited conditions, but also the identification of novel syndromes. The combination of potassium-sensitive periodic paralysis, ventricular arrhythmias and dysmorphism, initially described by Andersen and Tawil, represents such a novel condition. We report a case in which genetic analysis led to the diagnosis of Andersen-Tawil syndrome after 15 years of protracted non-invasive and invasive investigations from initial presentation to ultimate diagnosis in a young female. In conclusion, we describe the clinical and genetic features of Andersen-Tawil syndrome and demonstrate the utility of genetic testing in the diagnosis of cardiovascular disease.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19223265     DOI: 10.1016/j.ijcard.2009.01.057

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Systems pharmacology of arrhythmias.

Authors:  Seth I Berger; Avi Ma'ayan; Ravi Iyengar
Journal:  Sci Signal       Date:  2010-04-20       Impact factor: 8.192

2.  Vanishing Weakness and Persistent Cardiac Dysrhythmia: Are We Dealing with Andersen Tawil Syndrome?

Authors:  P Jhansi Rani; P Yashodhara; N V Sundarachary; U Veeramma; Shaik Mansoor Elahi; Sridhar Amalakanti; A Lalitha
Journal:  Indian J Pediatr       Date:  2015-01-25       Impact factor: 1.967

3.  Bioelectric signalling via potassium channels: a mechanism for craniofacial dysmorphogenesis in KCNJ2-associated Andersen-Tawil Syndrome.

Authors:  Dany Spencer Adams; Sebastien G M Uzel; Jin Akagi; Donald Wlodkowic; Viktoria Andreeva; Pamela Crotty Yelick; Adrian Devitt-Lee; Jean-Francois Pare; Michael Levin
Journal:  J Physiol       Date:  2016-04-13       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.